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Precision health seeks to optimise behavioural interventions by delivering personalised support to those in need,
when and where they need it. Conceptualised a decade ago, progress toward this vision of personally relevant
and effective population-wide interventions continues to evolve. This scoping review aimed to map the state of
precision health behaviour change intervention research.
This review included studies from a broader precision health review. Six databases were searched for studies
published between January 2010 and June 2020, using the terms ‘precision health’ or its synonyms, and
including an intervention targeting modifiable health behaviour(s) that was evaluated experimentally.
Thirty-one studies were included, 12 being RCTs (39%), and 17 with weak study design (55%). Most in
terventions targeted physical activity (27/31, 87%) and/or diet (24/31, 77%), with 74% (23/31) targeting two
to four health behaviours. Interventions were personalised via human interaction in 55% (17/31) and digitally in
35% (11/31). Data used for personalising interventions was largely self-reported, by survey or diary (14/31,
45%), or digitally (14/31, 45%). Data was mostly behavioural or lifestyle (20/31, 65%), and physiologic,
biochemical or clinical (15/31, 48%), with no studies utilising genetic/genomic data.
This review demonstrated that precision health behaviour change interventions remain dependent on humanled, low-tech personalisation, and have not fully considered the interaction between behaviour and the social and
environmental contexts of individuals. Further research is needed to understand the relationship between per
sonalisation and intervention effectiveness, working toward the development of sophisticated and scalable
behaviour change interventions that have tangible public health impact.

1. Introduction
Non-communicable diseases (NCDs) such as cardiovascular disease,
type 2 diabetes, chronic respiratory disease, and cancers are leading
causes of death, illness, and disability globally (World Health Organi
zation, 2018). These conditions are driven by modifiable lifestyle be
haviours including physical inactivity, unhealthy diet, smoking, and

alcohol consumption, which are causally linked to NCD development by
increasing blood pressure, glucose and lipid levels, and weight (World
Health Organization, 2018). The Global Burden of Disease study found
that more than 11 million deaths were attributed to suboptimal diets in
2017 (Afshin et al., 2019); while a further 6 million were attributed to
tobacco smoking alone (Reitsma et al., 2017). NCDs threaten the health
and well-being of populations globally and convey large social, medical,
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Khoury et al., 2016; Payne and Detmer, 2020).
Leading examples of precision health initiatives highlight the po
tential future impact of this approach. The United States Centers for
Disease Control's Tier 1 Genomic Applications (Centers for Disease
Control Prevention, 2020) leverages genomic data to achieve early
detection and intervention of serious health conditions such as heredi
tary breast and ovarian cancer syndrome (HBOC). The initiative in
cludes pre-specified pathways to impact that consider the individual's
socioeconomic factors and that include counselling, behaviour change,
and education interventions. This initiative, in context with comple
mentary initiatives to increase the impact of cancer prevention pro
grams, has been attributed to substantial increases in disease prevention
activities and impact, such as a two-fold increase in genetic counselling
for individuals at risk of HBOC (Green et al., 2019).
Questions remain, however, as to what extent the vision of an inte
grative precision health future has been realised in health behaviour or
preventive health research. Although the term 'precision health' was
conceptualised a decade ago, to what extent do corresponding health
behaviour interventions tailor their content based on individual-level
omic data, personal, and environmental characteristics? To what
extent has the ‘precision’ of this approach been realised, and is it suc
cessful in improving the health of populations? To answer these ques
tions and identify both promising lines of research as well as current
gaps, a scoping review was undertaken.

and economic costs (Ghebreyesus, 2018; Bloom et al., 2012; WHO,
2020). These costs are projected to exceed a cumulative output loss of
$47 trillion by 2030, with lower- and middle- income countries
contributing an increasing share of the burden (Bloom et al., 2012). In
addition to unhealthy lifestyle behaviours, NCDs are also influenced by a
complex range of interrelated factors including individual psychological
and physiological (genetic, epigenetic, microbiome, metabolomic, car
diovascular, etc.) profile, and the social determinants of health - the
social, economic, cultural, and physical environments in which people
live and work (Marmot and Bell, 2019; Prüss-Ustün et al., 2019; Glasgow
et al., 2018; Olstad and McIntyre, 2019).
Public health seeks to improve health and reduce health disparities
on a population scale (Binns and Low, 2015). Prevention of NCDs by
targeting modifiable lifestyle behaviours with cost-effective populationwide interventions is therefore a cornerstone of public health (Masters
et al., 2017; Bertram et al., 2018). Research has shown that primary
prevention interventions targeting nutrition, physical activity, smoking
status, and medication adherence are effective in preventing or reducing
the severity of NCDs (Schellenberg et al., 2013; Abbate et al., 2020).
However, prevalence of NCDs and their associated impact on public
health continues to be a major concern (World Health Organization,
2013). Traditionally, public health behaviour change interventions have
taken a ‘one-size-fits-all’ approach where the same intervention is pro
vided to each person, regardless of their personal or contextual risk
factors. However, NCD risk factors are dynamic and interrelated,
meaning that each person has a unique and complex risk profile that
varies over time. Thus, the public health impact of population-wide
interventions could be enhanced by personalising them to generally
accepted indicators of health, making them more personally relevant,
and therefore engaging and effective (Schoeppe et al., 2016; Tong et al.,
2021).
Precision health is one such approach to optimizing interventions by
ensuring the delivery of the right support, to the right individual, at the
right time (Weeramanthri et al., 2018; Hekler et al., 2020; Kee and
Taylor-Robinson, 2020; Bayer and Galea, 2015; Chen and Snyder, 2013;
Collins and Varmus, 2015). Precision health seeks to reduce NCDs by
personalising interventions to an individual's genetic, omic (genomic,
transcriptomic, lipidomic, proteomic, metabolomic, phenomic, radio
mic, and microbiomic), clinical, behavioural, social, and environmental
risk profile (Gambhir et al., 2018; Hickey et al., 2019). In the early stages
of precision medicine, which was considered as the predecessor of pre
cision health (Juengst and McGowan, 2018), pharmacologic in
terventions were personalised using an individual's genetic profile, such
as using BRCA1 status for predicting response to chemotherapy treat
ment (Narod, 2010). Recent advances in precision health and unprece
dented access to big data has presented new opportunities for
personalisation. These advances make it possible to move beyond per
sonalisation by static subgroup characteristics toward the integration of
multiple data types, including those relating to social determinants of
health, for individual-level tailoring (Viana et al., 2021a). For example,
a recent initiative has integrated metabolomics with microbiome,
inflammation and behavioural information, to develop pathways for
better management of disease symptoms, such as cancer fatigue (Sleight
et al., 2022). New and emerging technologies including smartphone
devices, wearable sensors, virtual and augmented reality, smart home
sensors, and applications of artificial intelligence have also played an
increasingly central role in the operationalisation of precision health
(Silvera-Tawil et al., 2020). These technologies are becoming a focal
point for precision health due to their role in enabling the collection,
analysis, and actionability of health, behavioural, and environmental
information (Silvera-Tawil et al., 2020). In order for precision health
interventions to be effective and equitable, they must simultaneously
take interindividual variability into account while retaining the poten
tial to be delivered on a population-wide scale to maximise their public
health impact by reducing the economic, social, and health-related
burdens of NCDs (Hekler et al., 2020; Kee and Taylor-Robinson, 2020;

1.1. Aims
The primary objective of this scoping review is to map the current
state of precision health behaviour change intervention research. More
specifically, this study addresses the following questions: (1) What are
the health behaviours being targeted by precision health behavioural
interventions?; (2) How are the interventions personalised?; and (3)
How successful are they at changing behaviour?
2. Methods
This review follows the methodological and reporting guidelines set
by the Joanna Briggs Institute (Peters et al., 2015) and the Preferred
Reporting Items for Systematic Reviews and Meta-analysis (PRISMA)
Extension for Scoping Reviews (PRISMA-ScR) (Tricco et al., 2018).
2.1. Protocol and registration
This review is part of a broader study, the Precision Health Scoping
Review, which sought to identify and describe all studies labelled as
precision health research, evaluate the extent to which they have
collected different data types, and determine which of the key stages of
the Gambhir et al. 2018 precision healthcare model they address; risk
assessment, customised monitoring, data analytics, and/or personalised
intervention (Gambhir et al., 2018). The Precision Health Scoping Re
view and its protocol have been published elsewhere (Ryan et al., 2021;
Viana et al., 2021b). The current paper extensively presents and ap
praises results from studies included in the original review that experi
mentally evaluated an intervention targeting at least one modifiable
health behaviour.
2.2. Eligibility criteria
The aim of the original precision health scoping review was to pro
vide a broad overview of ‘precision health’ in publications using this
term; therefore, few restrictions were placed on eligible studies. Studies
were eligible if they were (1) published between 1st of January 2010
(when precision health was distinguished from precision medicine) and
30th of June 2020; (2) included the term ‘precision health’ or its syno
nyms (‘personalised health’, ‘stratified health’, ‘tailored health’, and
‘individualised health’) (Ali-Khan et al., 2016) in the title or abstract and
2
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(3) in the introduction, methods, or results sections. As an example, the
search strategy for Scopus was as follows: '(TITLE ((precision OR per
sonali* OR individuali* OR stratif* OR tailo*) PRE/0 health) OR ABS
((precision OR personali* OR individuali* OR stratif* OR tailo*) PRE/
0 health)).' Lastly, (4) studies were required to have a clearly defined
health or medical outcome. Although we acknowledge various modal
ities (e.g. genomic medicine, precision oncology) and large-scale ini
tiatives (e.g. UK Biobank, All of Us, Million Veteran Program) that relate
to and/or enable a precision health system by collecting and integrating
multiple data types, we designed our original search strategy to broadly
capture studies characterised by the authors as ‘precision health’.
Studies were eligible for inclusion in the present review if they (5)
targeted one or more health behaviours and (6) experimentally evalu
ated the intervention. Eligibility was not limited to a certain population,
concept (e.g., chronic disease, non-communicable disease), or context
(e.g., high income countries, community settings).

reviewed scientific literature and grey literature: Medline (via Ovid),
Embase, Scopus, Web of Science, PsycINFO, and Google Scholar (first
300 results only). The reference lists of relevant primary studies and
reviews, and publication lists on websites of precision health research
groups were hand searched. Search results were exported into the sys
tematic review software Covidence (Veritas Health Innovation), where
duplicates were removed, and all stages of article screening were con
ducted in independent duplicate. Discrepancies were resolved through
discussion between the two reviewers and a third independent team
member. Articles were screened first by title, then abstract, and finally,
full text.
2.4. Data charting
A data charting template with item definitions was drafted and
piloted on two studies by three review team members. Data were
charted independently in duplicate, and disagreements were resolved by
a third independent review team member. Data were extracted on study
characteristics (e.g., design), participant characteristics (e.g., age, sex),
intervention features (e.g., behaviour(s) targeted, duration), person
alisation features (e.g., how the personalisation was done), outcome

2.3. Search strategy and information sources
To ensure optimal coverage of health and medical literature (Bramer
et al., 2017), searches were performed in six databases covering peer-

Fig. 1. Preferred reporting items for systematic review and meta-analyses (PRISMA) statement flow diagram.
3
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measures (measurement tool and timing), and key study results.
Quality of the included studies was assessed using the 11 items from
the Effective Public Healthcare Panacea Project (Thomas et al., 2004)
which gives a global quality rating of weak, moderate or strong, based
on selection bias, study design, confounders, blinding, data collection
tools, reporting of withdrawals, and dropouts. The 4-item intervention
intensity assessment tool was used to assess the overall intensity of each
included intervention in relation to intervention duration, numbers of
touchpoints, levels of contact, and settlings/reach (Hendrie et al., 2013).
The full data charting template is included in Appendix A.

half (13/31, 42%) of the studies had a sample with a mean age between
51 and 70 years. Of the 30 studies reporting the sex of participants, the
average percentage of female participants was 59.1% (SD 27.3%), with
six studies including only females and one study only males. Half of the
studies (15/31, 48%) were focused on improving health behaviour or
related outcomes in a general population, with the remaining half (16/
31, 52%) targeting people with specific health conditions. Mean inter
vention duration was around six months (25 weeks, SD 20), ranging
from a one-off interaction, to two years.
3.2. Study characteristics

3. Results

Table 2 describes individual study characteristics. Most interventions
targeted weight-related behaviours including physical activity (27/31,
87%) and dietary intake (24/31, 77%), with the majority (23/31, 74%)
targeting two to four health behaviours. Few studies solely focused on
one health behaviour (4/31, 13%). Around 40% of the studies (12/31)
were conducted with the explicit aim of changing health behaviour,
while a quarter (8/31, 26%) aimed to prevent or manage a medical
condition. Half (16/32, 52%) of the studies delivered high-intensity
interventions, as measured by intervention duration, frequency of con
tact, type of contact, and reach.

Of the 225 studies included in the primary scoping review, 31
(13.8%) were eligible for the present study (Fig. 1). (An et al., 2013;
Anderson et al., 2015; Arens et al., 2018; Berks et al., 2019; Chua et al.,
2011; Colkesen et al., 2011; de Vries et al., 2012; Dreer et al., 2016;
Elbert et al., 2016; Gilmore et al., 2017; Haslam et al., 2019; Kim et al.,
2015; Lee et al., 2012; Leinonen et al., 2017; Lim et al., 2011; Liu, 2018;
Liu et al., 2019; McHugh and Suggs, 2012; Nakamura et al., 2018; Oh
et al., 2014; Qin et al., 2019; Rabbi et al., 2015; Sadat Rezai et al., 2019;
Samaan et al., 2013; Sun et al., 2019; Tucker et al., 2016; van den
Brekel-Dijkstra et al., 2016; van Limpt et al., 2011; Youm and Liu, 2017;
Zhou et al., 2010; Drake et al., 2018)

3.2.1. Intervention personalisation process
Table 3 describes the personalised components of the interventions
across the included studies. Intervention content was personalised
manually (i.e., via human interaction) in over half of the studies (17/31,
55%), and automatically via a digital platform with inbuilt algorithms or
decision rules in just over a third of studies (11/31, 35%). Advice or
coaching in relation to lifestyle and behavioural factors was the inter
vention component personalised most often (23/31, 74%). Intervention
delivery occurred in a single setting, such as an app or individual con
sultations, around half of the time (14/31, 45%) (Table 2). The most
common delivery methods were websites (12/31, 39%) and telephone
(12/31, 39%), followed by face-to-face individual consultations or in
terviews (11/31, 35%) and mobile applications (8/31, 26%). Person
alisation occurred on a daily basis in eight studies (26%) and weekly to
fortnightly in seven studies (23%), while nine studies (29%) did not
specify the frequency of personalisation of intervention content. Infor
mation used to personalise interventions was most commonly behav
ioural or lifestyle data (20/31, 65%); physiologic, biochemical or
clinical data (15/31, 48%); psychological or psychiatric data (12/31,
39%); or anthropometric data (12/31, 39%). Most (23/31, 74%) studies
used two to four data types to personalise intervention content, with the
mean (SD) being 2.8 (1.4). Genetic or genomic data was not utilised in
any of the included studies. Data were largely obtained via self-report,
either by survey or diary (14/31, 45%) or digitally (14/31, 45%).

3.1. Summary of studies
Table 1 summarises the included studies. Just under half of the
studies (12/31, 39%) were randomised controlled trials (RCTs). In terms
of methodological rigour, only seven studies (23%) were scored as
strong, seven as moderate (23%), and the remaining 17 (55%) were
weak. Sample size varied from 11 to more than 47,000 participants,
although 12 studies (39%) recruited less than 100 participants. Almost
Table 1
Summary of included studies targeting health behaviour (N = 31).
Characteristic

Category

n (%)

Country of sample population

USA
The Netherlands
Korea
China
Others
18–30
31–50
51–70
71+
0–100
101–500
501+
Randomised controlled trial
Case-control study
Cohort study
Others
No condition / general population
Heart disease
Type 2 diabetes
People with overweight or obesity
Others
Physical activity
Dietary intake
Smoking
Alcohol or drug use
Medication adherence
Sleep
Others
Weak
Moderate
Strong

9 (29)
6 (19)
5 (16)
4 (13)
7 (23)
4 (14)
11 (38)
13 (45)
1 (3)
12 (39)
13 (42)
6 (19)
12 (39)
7 (23)
5 (16)
7 (23)
15 (48)
4 (13)
3 (10)
3 (10)
6 (19)
27 (87)
24 (77)
11 (35)
6 (19)
5 (16)
4 (13)
8 (26)
17 (55)
7 (23)
7 (23)

Sample age in years (mean)a

Sample size
Study design

Clinical condition of sample

Health behaviour targetedb

Quality score

a
b

3.3. Digitally personalised versus human-led personalised interventions
Digital interventions more commonly personalised ‘feedback on
behaviour’ (7/11, 64% of studies) compared with those interventions
personalised by humans (1/17, 6%) (data not presented). Interventions
personalised by humans more frequently made use of psychologic or
psychiatric data (8/17, 47%), and perspective or opinion data (7/17,
41%), than those personalised digitally (4/11, 36% and 3/11, 27%
respectively). Digitally personalised interventions utilised a greater
number of data types compared with those personalised manually (i.e.
by human interaction) (mean ± SD of 3.4 ± 1.1 versus 2.6 ± 1.5,
respectively).
3.4. Intervention efficacy
Around 60% of the studies (18/31) reported a statistically significant
result in favour of the intervention relating to the primary outcome
measure or equivalent (see Appendix B). Only half of the 12 RCTs

Mean age of sample not reported in n = 2 studies.
Most studies (74%) targeted more than 1 health behaviour.
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Table 2
Characteristics of precision health studies targeting health behaviour (N = 31).
Study

5

Country

Design

An 2013 (An et al., 2013)

USA

RCT

W

24.1

Anderson 2015 (Anderson
et al., 2015)
Arens 2018 (Arens et al.,
2018)
Berks 2019 (Berks et al.,
2019)
Chua 2011 (Chua et al.,
2011)
Colkesen 2011 (Colkesen
et al., 2011)
deVries 2012 (de Vries
et al., 2012)
Drake 2018 (Drake et al.,
2018)
Dreer 2016 (Dreer et al.,
2016)
Elbert 2016 (Elbert et al.,
2016)
Gilmore 2017 (Gilmore
et al., 2017)
Haslam 2019 (Haslam et al.,
2019)
Kim 2015 (Kim et al., 2015)
Lee 2012 (Lee et al., 2012)

AUS

RCT

S

DEU

Cohort

NLD
USA

Leinonen 2017 (Leinonen
et al., 2017)
Lim 2011 (Lim et al., 2011)
Liu 2018 (Liu, 2018)

Sample age in
yrs (M ± SD)b

Sample size
(I gp(s)/C)c

Clinical
sample

Int
type

Int
intensity

Primary health
outcome/Behavioural
target

Health behaviour targets
PA

Diet

Smoking

Alcohol/
drugs

N

D,T

Low

Smoking

✓

✓

✓

✓

49.2 ± 6.2

566/565/
567
26/29

Y

High

✓

✓

✓

49.6 ± 9.3

109/57

Y

High

Menopausal
symptoms
Weight

✓

W

D,W,
T
G,D

✓

✓

Cohort

W

31.6 ± 4.2

144/62

Y

I,D,T

High

CVD risk

✓

✓

Prepost
Cohort

W

37.5 ± 11.5

91/0

N

High

Smoking

W

46.0 ± 7.8

368/404

N

I,T,
M, W
D,I

Low

CVD risk

Prepost
CCT

W

46.2

387/0

Y

D

Low

Skin protection

W

59.4 ± 10.5

17/16

Y

I,G

High

T2DM management

M

61.0 ± 7.0

11/0

Y

I,T

Medium

NLD

Prepost
RCT

M

41.4 ± 14.6

N

D

Low

USA

RCT

W

26.0 ± 5.2

114/113/
115
20/20

Glaucoma med
adherence
Dietary intake

Y

D,T

Medium

Weight

✓

GBR

NRCT

W

42.1 ± 10.5

N

W

High

Physical activity

✓

KOR
KOR

CCT
Prepost
RCT

S
S

65.7 ± 5.0
53.4 ± 14.3

431/471/
218
35/35
69/0

Y
N

D,T,I
D

High
Low

✓
✓

S

17.8 ± 0.6

250/246

N

D

High

T2DM management
Weight & blood
pressure
Physical activity

✓

NLD
NLD
USA
USA

FIN
KOR
USA

Med
adherence

Sleep

Otherd

✓

✓
✓

✓

✓

✓
✓

✓

✓

✓

✓

✓
✓
✓

✓
✓

✓
✓

✓
✓
✓

S
M

67.2 ± 4.1
48.0 ± 10.7

51/51/52
297/0

Y
Y

D
I,T,D

High
Medium

T2DM management
Depression

✓
✓

✓
✓

CHN
USA

RCT
Prepost
CCT
CCT

W
M

53.5 ± 6.3
41.0 ± 9.3

49/49
101/137

Y
Y

D
D,W

Low
Medium

Burden & fatigue
Weight

✓
✓

✓
✓

JPN

Cohort

M

53.1e

Y

Smoking

✓

✓

S
M
W

66.2 ± 8.2
53.5 ± 9.4
NS

N
Y
N

High
Low
High

Bone health
Burden & fatigue
Weight

✓
✓
✓

✓
✓
✓

CAN

RCT
CCT
Prepost
CCT

I,T,
W, D
G,M
D
D

High

KOR
CHN
USA

4683/2392/
31202/9450
21/20
49/49
16/0

W

23.6 ± 5.8

40/40/40

N

D

Low

Physical activity

✓

CAN

RCT

M

53.8 ± 11.4

182/185

N

D

Medium

CVD risk

✓

✓

CHN
USA

RCT
RCT

W
W

68.2 ± 4.7
43.0 ± 12.4

50/50
27/13/0

Y
N

I,T,D
D

High
High

Physical activity
Physical activity

✓
✓

✓

✓

✓

✓

✓

✓
✓

✓
✓
✓

✓

✓
✓
✓
(continued on next page)
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Liu 2019 (Liu et al., 2019)
McHugh 2012 (McHugh
and Suggs, 2012)
Nakamura 2018 (Nakamura
et al., 2018)
Oh 2014 (Oh et al., 2014)
Qin 2019 (Qin et al., 2019)
Rabbi 2015 (Rabbi et al.,
2015)
Rezai 2019 (Sadat Rezai
et al., 2019)
Samaan 2013 (Samaan
et al., 2013)
Sun 2019 (Sun et al., 2019)
Tucker 2016 (Tucker et al.,
2016)

Quality
Scorea

C.E. Mauch et al.

Table 3
Personalisation details of study interventions targeting health behaviour (N =
31).

CCT = controlled clinical trial; NRCT = non-randomised controlled trial; RCT = randomised controlled trial; G = group; I = individual (face-to-face consultations/interviews); D = digital, i.e. website, app, text message; T
= telephone; W = written materials; M = medication or supplements; CVD = cardiovascular disease; NS = not specified; QOL = quality of life.
a
Assessed using the Effective Public Health Practice Project Quality Assessment Tool for Quantitative Studies (ref): W = weak; M = moderate; S = strong.
b
Mean age of intervention group only where mean age of total sample was not reported.
c
Total sample size reported where size of intervention / control groups were not reported separately.
d
Other includes: sedentary time, stress reduction/management, skin protection & self-monitoring of blood glucose levels.
e
Mean age of the males in the sample.

✓
✓
General lifestyle /
QOL
High
I
N
1156/1038
71.5 ± 7.4
RCT
CHN

S

✓
CCT
KOR

W

NS

143

N

D

Medium

Physical activity

✓

✓

✓

✓
✓
✓
CVD risk
RCT
NLD

W

62.2

618/657

Y

I,T

High

✓
CVD risk
Cohort

van den Brekel-Dijkstra
2015 (van den BrekelDijkstra et al., 2016)
van Limpt 2011 (van Limpt
et al., 2011)
Youm 2017 (Youm and Liu,
2017)
Zhou 2010 (Zhou et al.,
2010)

NLD

W

52.2 ± 6.3

230/0

N

D

Low

✓

✓
✓

✓

Smoking
Diet
PA

Primary health
outcome/Behavioural
target
Study

Table 2 (continued )

Country

Design

Quality
Scorea

Sample age in
yrs (M ± SD)b

Sample size
(I gp(s)/C)c

Clinical
sample

Int
type

Int
intensity

Health behaviour targets

Alcohol/
drugs

Med
adherence

✓

Sleep

Otherd
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Personalisation aspect

Category

n (%)

Personalisation process

Human – Practitioner/interventionist
led
Digital – Algorithm/decision rule
based
Digital & human
Not specified / unclear
Lifestyle/behavioural advice or
coaching
Health education content

17
(55)
11
(35)
2 (6)
1 (3)
23
(74)
14
(45)
11
(35)
10
(32)
12
(39)
12
(39)
11
(35)
8 (26)
5 (16)
5 (16)
3 (10)
3 (10)
1 (3)
1 (3)
8 (26)
7 (23)
4 (13)
3 (10)
9 (29)
20
(65)
15
(48)
12
(39)
12
(39)
11
(35)
10
(32)
8 (26)
1 (3)
14
(45)
14
(45)
9 (29)

Personalised intervention
components

Goal setting
Feedback on behaviour or health
Delivery of personalised content

Website
Telephone
Face-to-face – Individual
Mobile application
Email
Written materials
Face-to-face – Group
Text message
Computer software

Frequency of personalisationa

Data types usedb

Tracking device
Daily
Weekly to fortnightly
Monthly
Once
Not specified
Behavioural / lifestyle
Physiologic / biochemical / clinical
markers
Psychologic / psychiatric
Anthropometric
Perspective / opinion
Sociodemographic / economic

Source of data

Diet / nutritional
Socioenvironmental
Self-report via survey/diary
Self-report via app input or web
Self-report at interview (incl via
telephone)
Tracking/monitoring/smart device
In-person health assessment

5 (16)
2 (6)

a

Where frequency varied across the intervention, the most frequent period of
intervention is reported.
b
Data type category descriptions/examples: Behavioural / lifestyle = physical
activity, smoking, drinking, sleep; Physiologic / biochemical / clinical markers
= blood pressure, blood glucose, metabolites; Psychologic / psychiatric =
quality of life, depression, anxiety; Anthropometric = height, weight, body mass
index (BMI); Perspective / opinion = opinion on or evaluation of a particular
technology/concept; life/lived experiences; Sociodemographic / economic =
age, sex, income; Diet / nutritional = food or nutrient intake; Socio
environmental = exposure to pollutants, housing conditions, size of household/
family.

reported significant primary outcomes in favour of the intervention
group. A quarter of the studies (8/31, 26%) did not measure or report on
any health behaviours targeted by the interventions, while 45% (14/31)
reported outcomes relating to all of the health behaviour targets.
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4. Discussion

It is worth noting that the lack of studies that utilise genetic/genomic
information and other data types for behavioural interventions does not
mean that these studies do not exist. Since our initial scoping review
primarily captured studies that explicitly use the term ‘precision health’,
different labelling of these studies (such as precision medicine) may
have meant they were not captured within our search strategy.
Previously, evaluations of personalised health interventions have
focused on either clinical, one-to-one (patient-centred) care (Booth
et al., 2014), or digital health that utilises computer algorithms and
other automated processes to deliver a personalised program (Ryan
et al., 2019; Sahin et al., 2019). This review suggests that in precision
health, both human-led personalisation and digital personalisation
processes requiring human input (e.g. of behavioural data) continue to
dominate. ‘Hands off’ approaches harnessing health-monitoring devices
for data collection and intelligent algorithms for personalisation of
health interventions are often regarded as an ideal approach, due to
their scalability and potential cost-effectiveness (Kostkova, 2015). This
is despite the well-documented challenges in achieving sufficient user
engagement in digital interventions (Yardley et al., 2016; Yeager and
Benight, 2018). In the reviewed studies, reliance on human-led, lowtech personalisation may limit the potential for cost-effective scale-up of
behaviour change interventions. However human contact and input
could lead to greater engagement and long-term behaviour change,
whilst also being more relevant and acceptable to populations experi
encing the digital divide (Makri, 2019; Mubarak and Suomi, 2022) and
those with mistrust of digital technologies (Figueroa et al., 2022). The
optimal balance between human and digital input for maximising
intervention efficacy and cost-effectiveness requires further exploration
in RCTs and health economic assessments (Michie et al., 2017).
Despite the popularity of digital intervention delivery evident in this
study, risk assessment, monitoring, and data analytics remain largely
reliant on research participants via self-reported data and health prac
titioners. The precision healthcare model proposed by Gambhir et al.
2018 demonstrates how digital technologies could contribute to data
collection and monitoring, risk assessment and data analytics (Gambhir
et al., 2018). Future behavioural interventions could leverage advances
in wearables to simplify data collection and monitoring, while machine
learning and predictive modelling could be used to enhance data ana
lytics and risk assessment. More objective, technology-driven measure
ment and assessment of human health, behaviour, and context would
improve intervention scalability and support the delivery of timely and
relevant precision health behavioural interventions.
Only half of the 12 RCTs in this study reported statistically significant
outcomes in favour of the intervention, and less than half reported
outcomes on all relevant behavioural targets. This may reflect the
mainly weak study design of the included studies, but perhaps also the
early stage of research in which the field currently stands. Thus, preci
sion health behavioural intervention research should employ more
rigorous and efficient study design to fully understand the effects of
individual intervention components on relevant behavioural outcomes.
Just-in-the-Moment Adaptive Interventions (Wang and Miller, 2020),
Multiphase Optimization Strategy or Sequential Multiple Assignment
Randomised Trials with factorial experiments (Collins et al., 2007)
would support more efficient testing and optimisation of complex
behavioural interventions. Pragmatic or real-world trials would also
ensure the successful translation and community implementation of
research in the rapidly advancing field of precision health.

4.1. Summary
The bold vision of precision health – to personalise and thus trans
form preventive health care through the integration of multiple data
types – is expected to take decades to fully realise (Gambhir et al., 2018).
In this review, we included studies characterised as ‘precision health’
that evaluated a personalised health intervention. Although no study on
its own fully reflected precision health's vision of integrating a wide
range of information for health promotion, isolated components of this
model were evident throughout the included studies (Gambhir et al.,
2018). The majority of studies evaluated interventions that were multicomponent, typically targeting a combination of behavioural risk factors
including physical activity, diet, and/or smoking. Intervention person
alisation typically involved personalised lifestyle advice, behavioural
goals, and/or feedback on behaviour or health condition(s). In most
cases, the personalisation process was human-led or involved human
interaction, while a smaller group of studies employed digital person
alisation processes, such as the provision of personalised feedback on
past or current health behaviour entered into an app or website. While
most studies reported statistically significant effects in favour of the
intervention, they were mainly of weak or moderate quality and just 12
RCTs were identified in the sample of 31. This review has identified the
outstanding questions that must be answered to truly make progress
toward a precision healthcare future.
4.2. Comparison with previous literature
Precision health interventions should be holistic, delivering behav
ioural support to those in need when and where they need it most. In
terventions included in this review were multi-component, often
targeting two to four behaviours simultaneously. This is consistent with
previous reviews that have also identified a high prevalence of multicomponent health behaviour change interventions (Roberts et al.,
2017; Booth et al., 2014; Ryan et al., 2019). The co-occurrence of un
healthy lifestyle behaviours related to energy balance (e.g. dietary
intake and activity) and addiction (e.g. smoking and alcohol intake)
(Samaan et al., 2013) means that multi-component interventions are key
to maximising impact upon downstream health outcomes. Although the
outcomes of multi-component health behaviour change interventions
remain mixed, the largest effects have so far been seen in at-risk pop
ulations (Samaan et al., 2013; Sun et al., 2019). Precision health in
terventions utilising continuous health monitoring and big data
analytics are well placed to improve the health behaviour of these
populations through enhanced risk assessment and early disease detec
tion. However, study efficacy with respect to multiple health behaviour
change was difficult to assess in the included studies, due to the lack of
reporting of behavioural outcomes relating to some or all of the health
behaviours targets, along with substantial heterogeneity in study design.
Thus, the efficacy of precision health interventions in addressing mul
tiple, co-occurring health behaviours remains unclear.
In this review, precision health was most commonly operationalised
as the delivery of personalised intervention content based on inputs of
behavioural and lifestyle information (e.g., physical activity levels),
clinical and biochemical markers, psychological information, or
anthropometric data. The reviewed studies did not realise the vision of
precision health for behavioural interventions, wherein genetic or
genomic, and contextual information, such as the social and built
environment, are integrated to deliver personally relevant interventions
(Gambhir et al., 2018). Current approaches appear to reflect next gen
eration personalised interventions focusing primarily on the previous or
current health behaviour of the individual and/or personalisation ac
cording to discrete subgroup characteristics. The social and environ
mental contexts of individuals, and how these change over the life
course, along with their genetic profile, have not been fully considered.

4.3. Outstanding research questions
This review highlights some outstanding research questions with
respect to precision health in behaviour change interventions which
should be addressed in future research:
1. How can precision health interventions effectively target multiple,
co-occurring health behaviours?
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2. What is the effectiveness of interventions that are personalised by
humans, an algorithm, or a combination of both? Furthermore, what
is the best metric to judge effectiveness?
3. Can ‘light touch’ digital interventions achieve the same level of
precision that can be achieved via human-led personalisation? And if
not, what is the necessary balance between digital and human-led
personalisation to maximise efficacy, scalability and costeffectiveness?
4. What are the barriers and enablers to the integration of genetic, so
cial and environmental data with behavioural, psychologic and user
preference data?
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4.4. Strength and limitations

Data availability

Strengths of this review included our broad search criteria, which did
not limit the included studies to those with a specific mode of delivery
(such as digital) or target population (such as those with a specific health
condition). Our search criteria also included numerous synonyms of
precision health (Ali-Khan et al., 2016), broadening the scope of this
review and facilitating richer analysis on how various ‘precision health’
studies integrate multiple types of information and personalise behav
ioural interventions. Finally, all stages of the review, from article
screening to data extraction, were conducted rigorously in independent
duplicate with discrepancies resolved through discussion with a third
adjudicator.
This study was not a systematic review; therefore, we did not
consider effect size or all study outcomes reported. Substantial hetero
geneity in study design and outcomes assessment meant that our work
was limited to a frequency count of intervention efficacy. Due to vari
ability in the terminology used to define precision health, it is unlikely
that we captured all precision or personalised interventions targeting
health behaviour. The search strategy used in our initial scoping review
did not include several terms associated with precision health such as
‘precision medicine’, or subfields of precision health, such as ‘precision
nutrition’, ‘precision oncology’, and ‘precision public health’. This
might have limited retrieval of articles using alternative terminology.
Finally, progress in the field of precision health and behavioural in
terventions is ongoing and future reviews will be needed to capture the
most recent evidence and to keep track of how these fields of research
are evolving over time.
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